Drug Profile
U 74500A
Latest Information Update: 20 Jul 2011
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Anti-ischaemics; Antiulcers; Nootropics
- Mechanism of Action Antioxidants; Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebral ischaemia; Cognition disorders; Craniocerebral trauma; Glioma; Myocardial infarction; Peptic ulcer; Spinal cord injuries; Transplant rejection
Most Recent Events
- 20 Jul 2011 Discontinued - Preclinical for Cerebral ischaemia in USA (unspecified route)
- 20 Jul 2011 Discontinued - Preclinical for Cognition disorders in USA (unspecified route)
- 20 Jul 2011 Discontinued - Preclinical for Craniocerebral-trauma in USA (unspecified route)